24342-60-7 Usage
Explanation
The compound is composed of 19 carbon atoms, 23 hydrogen atoms, 1 chlorine atom, and 2 nitrogen atoms.
2. Heterocyclic compound
Explanation
It contains a six-membered ring with two nitrogen atoms, making it a heterocyclic compound.
Explanation
The compound has a specific arrangement of atoms, with a 1,4-diazepine ring fused to a phenyl group and a 4-chlorophenyl group.
4. Pharmaceutical synthesis
Explanation
It is used in the synthesis of various pharmaceuticals and organic compounds.
5. Medicinal chemistry and drug development
Explanation
The compound has potential applications in medicinal chemistry and drug development due to its specific structural and chemical properties.
Explanation
The compound is known for its potential biological activities, making it an important chemical compound in the field of pharmaceutical research and development.
7. Potential therapeutic applications
Explanation
Due to its biological activities, the compound may be used in the development of new drugs for treating various diseases, including inflammation, cancer, and other conditions.
Chemical structure
1-[(4-Chlorophenyl)phenylmethyl]hexahydro-1H-1,4-diazepine
Biological activities
Anti-inflammatory, anti-tumor, and anti-cancer properties
Check Digit Verification of cas no
The CAS Registry Mumber 24342-60-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,3,4 and 2 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 24342-60:
(7*2)+(6*4)+(5*3)+(4*4)+(3*2)+(2*6)+(1*0)=87
87 % 10 = 7
So 24342-60-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H21ClN2/c19-17-9-7-16(8-10-17)18(15-5-2-1-3-6-15)21-13-4-11-20-12-14-21/h1-3,5-10,18,20H,4,11-14H2
24342-60-7Relevant articles and documents
Synthesis, Structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds
Burgess, Steven J.,Kelly, Jane X.,Shomloo, Shawheen,Wittlin, Sergio,Brun, Reto,Liebmann, Katherine,Peyton, David H.
experimental part, p. 6477 - 6489 (2010/11/05)
We have previously shown that a "reversed chloroquine (RCQ)" molecule, composed of a chloroquine-like moiety and a resistance reversal-like moiety, can overcome chloroquine resistance in P. falciparum (Burgess, S. J.; Selzer, A.; Kelly, J. X.; Smilkstein, M. J.; Riscoe, M. K.; Peyton, D. H. J. Med. Chem. 2006, 49, 5623. Andrews, S.; Burgess, S. J.; Skaalrud, D.; Kelly, J. X.; Peyton, D. H. J. Med. Chem. 2010, 53, 916). Here, we present an investigation into the Structure-activity relationship of the RCQ structures, resulting in an orally active molecule with good in vitro and in vivo antimalarial activity. We also present evidence of the mode of action, indicating that the RCQ molecules inhibit hemozoin formation in the parasite's digestive vacuole in a manner similar to that of chloroquine.